Bravi D - Search Results

1

Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group.

Barone P, Bravi D, Bermejo-Pareja F, Marconi R, Kulisevsky J, Malagù S, Weiser R, Rost N. Barone P, et al. Among authors: bravi d. Neurology. 1999 Aug 11;53(3):573-9. doi: 10.1212/wnl.53.3.573. Neurology. 1999. PMID: 10449123 Clinical Trial.

2

Levodopa peak response time reflects severity of dopamine neuron loss in Parkinson's disease.

Sohn YH, Metman LV, Bravi D, Linfante I, Aotsuka A, Mouradian MM, Chase TN. Sohn YH, et al. Among authors: bravi d. Neurology. 1994 Apr;44(4):755-7. doi: 10.1212/wnl.44.4.755. Neurology. 1994. PMID: 8164839

3

End-of-dose dystonia in Parkinson's disease.

Bravi D, Mouradian MM, Roberts JW, Davis TL, Chase TN. Bravi D, et al. Neurology. 1993 Oct;43(10):2130-1. doi: 10.1212/wnl.43.10.2130. Neurology. 1993. PMID: 8413978

4

Catechol-O-methyltransferase inhibitor tolcapone prolongs levodopa/carbidopa action in parkinsonian patients.

Roberts JW, Cora-Locatelli G, Bravi D, Amantea MA, Mouradian MM, Chase TN. Roberts JW, et al. Among authors: bravi d. Neurology. 1993 Dec;43(12):2685-8. doi: 10.1212/wnl.43.12.2685. Neurology. 1993. PMID: 8255478 Clinical Trial.

5

Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications.

Verhagen Metman L, Locatelli ER, Bravi D, Mouradian MM, Chase TN. Verhagen Metman L, et al. Among authors: bravi d. Neurology. 1997 Feb;48(2):369-72. doi: 10.1212/wnl.48.2.369. Neurology. 1997. PMID: 9040723 Clinical Trial.

6

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

Bravi D, Mouradian MM, Roberts JW, Davis TL, Sohn YH, Chase TN. Bravi D, et al. Ann Neurol. 1994 Jul;36(1):27-31. doi: 10.1002/ana.410360108. Ann Neurol. 1994. PMID: 8024257

7

Acute administration of antipsychotics modulates Homer striatal gene expression differentially.

de Bartolomeis A, Aloj L, Ambesi-Impiombato A, Bravi D, Caracò C, Muscettola G, Barone P. de Bartolomeis A, et al. Among authors: bravi d. Brain Res Mol Brain Res. 2002 Jan 31;98(1-2):124-9. doi: 10.1016/s0169-328x(01)00327-8. Brain Res Mol Brain Res. 2002. PMID: 11834303

8

Pergolide protects SH-SY5Y cells against neurodegeneration induced by H(2)O(2).

Uberti D, Piccioni L, Colzi A, Bravi D, Canonico PL, Memo M. Uberti D, et al. Among authors: bravi d. Eur J Pharmacol. 2002 Jan 2;434(1-2):17-20. doi: 10.1016/s0014-2999(01)01537-0. Eur J Pharmacol. 2002. PMID: 11755160

9

Comparison between L-dopa and lisuride intravenous infusions: a clinical study.

Ruggieri S, Stocchi F, Carta A, Bravi D, Bragoni M, Giorgi L, Agnoli A. Ruggieri S, et al. Among authors: bravi d. Mov Disord. 1988;3(4):313-9. doi: 10.1002/mds.870030405. Mov Disord. 1988. PMID: 3211176

10

Treatment of Parkinson's disease with the partial dopamine agonist EMD 49980.

Bravi D, Davis TL, Mouradian MM, Chase TN. Bravi D, et al. Mov Disord. 1993 Apr;8(2):195-7. doi: 10.1002/mds.870080214. Mov Disord. 1993. PMID: 8097280 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters